Metronomic Capecitabine in Stage III Gastric Cancer
Clinical trial NCT06313567 · RECRUITING
Trial details
- NCT number
- NCT06313567
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-10
- Primary completion
- 2029-03-10
- Enrollment
- 722
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.